1. Home
  2. CRBU vs MPAA Comparison

CRBU vs MPAA Comparison

Compare CRBU & MPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • MPAA
  • Stock Information
  • Founded
  • CRBU 2011
  • MPAA 1968
  • Country
  • CRBU United States
  • MPAA United States
  • Employees
  • CRBU N/A
  • MPAA N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • MPAA Auto Parts:O.E.M.
  • Sector
  • CRBU Health Care
  • MPAA Consumer Discretionary
  • Exchange
  • CRBU Nasdaq
  • MPAA Nasdaq
  • Market Cap
  • CRBU 188.8M
  • MPAA 188.9M
  • IPO Year
  • CRBU 2021
  • MPAA 1994
  • Fundamental
  • Price
  • CRBU $1.90
  • MPAA $11.19
  • Analyst Decision
  • CRBU Strong Buy
  • MPAA
  • Analyst Count
  • CRBU 4
  • MPAA 0
  • Target Price
  • CRBU $8.50
  • MPAA N/A
  • AVG Volume (30 Days)
  • CRBU 1.8M
  • MPAA 127.4K
  • Earning Date
  • CRBU 08-12-2025
  • MPAA 08-11-2025
  • Dividend Yield
  • CRBU N/A
  • MPAA N/A
  • EPS Growth
  • CRBU N/A
  • MPAA N/A
  • EPS
  • CRBU N/A
  • MPAA N/A
  • Revenue
  • CRBU $9,918,000.00
  • MPAA $757,354,000.00
  • Revenue This Year
  • CRBU $9.52
  • MPAA $7.74
  • Revenue Next Year
  • CRBU N/A
  • MPAA $5.00
  • P/E Ratio
  • CRBU N/A
  • MPAA N/A
  • Revenue Growth
  • CRBU N/A
  • MPAA 5.53
  • 52 Week Low
  • CRBU $0.66
  • MPAA $5.16
  • 52 Week High
  • CRBU $3.00
  • MPAA $12.72
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 53.41
  • MPAA 47.42
  • Support Level
  • CRBU $1.86
  • MPAA $9.86
  • Resistance Level
  • CRBU $2.13
  • MPAA $12.43
  • Average True Range (ATR)
  • CRBU 0.22
  • MPAA 0.60
  • MACD
  • CRBU -0.05
  • MPAA -0.12
  • Stochastic Oscillator
  • CRBU 15.76
  • MPAA 43.89

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About MPAA Motorcar Parts of America Inc.

Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard part in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.

Share on Social Networks: